Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 1 art units • 1 examiners • 0 of 2 (0%) have an AI response strategy ready
A-Alpha Bio Inc. maintains 2 pending office actions in the Biotechnology & Pharmaceuticals technology area. These 2 actions are assigned to only 1 distinct examiner and 1 distinct art unit, creating a highly centralized prosecution environment for the company's current filings. Such concentration suggests that the pending matters are technically similar enough to be grouped under a single official's review.
RAYMONDA, MATTHEW HAROLD is the busiest examiner, holding all 2 pending office actions. This means that the company's immediate progress in the patent office is entirely dependent on the interpretations and timelines of this individual official. For practitioners, this provides a unique opportunity to develop a consistent rapport with a single examiner, as the outcome of one action is likely to influence the other.
The presence of only 1 distinct art unit for the 2 pending office actions simplifies the administrative burden but increases the impact of any specific examiner tendencies. Because RAYMONDA, MATTHEW HAROLD manages the entirety of the company's active cases, any delays or specific requirements from this examiner will affect the whole pending portfolio. Practitioners should prioritize understanding this examiner's past decisions to navigate the 2 pending actions effectively.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 2 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| RAYMONDA, MATTHEW HAROLD | 2 | 40.0% | +47.7% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18423075 | METHODS FOR IDENTIFYING PROTEIN CODING SEQUENCES USING DNA BARCODES | RAYMONDA, MATTHEW HAROLD | — |
| 18291791 | METHODS FOR IDENTIFYING PROTEIN CODING SEQUENCES USING DNA BARCODES | RAYMONDA, MATTHEW HAROLD | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18423075 | METHODS FOR IDENTIFYING PROTEIN CODING SEQUENCES USING DNA BARCODES | RAYMONDA, MATTHEW HAROLD | — |
| 18291791 | METHODS FOR IDENTIFYING PROTEIN CODING SEQUENCES USING DNA BARCODES | RAYMONDA, MATTHEW HAROLD | — |
| Art Unit | Apps |
|---|---|
| 1684 | 2 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18423075 | METHODS FOR IDENTIFYING PROTEIN CODING SEQUENCES USING DNA BARCODES | RAYMONDA, MATTHEW HAROLD | 1684 | §101§103§112 | Non-Final OA | — | Pending | Jan 25, 2024 |
| 18291791 | METHODS FOR IDENTIFYING PROTEIN CODING SEQUENCES USING DNA BARCODES | RAYMONDA, MATTHEW HAROLD | 1684 | §101§103§112 | Non-Final OA | — | Pending | Jan 24, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialA-Alpha Bio Inc. has 2 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Matthew Harold Raymonda has the most, with 2 of A-Alpha Bio Inc.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
